Table 4.
Effect of COVID-19 on healthcare costs measured by DiD-estimates (in €)
|
Effect of C19
in total |
Effect of C19
PCS patients only |
Effect of C19
excl. PCS patients |
|
|---|---|---|---|
|
Total healthcare costs ≤ 19 years 20–39 years 40–59 years ≥ 60 years |
1063 65 483 1422 2012 |
3242 655 2176 3309 5010 |
727 13 274 985 1604 |
|
Hospital costs ≤ 19 years 20–39 years 40–59 years ≥ 60 years |
675 252 18 835 1884 |
1991 307 1020 2135 3538 |
471 235 -142 553 1656 |
|
Costs of outpatient med. care ≤ 19 years 20–39 years 40–59 years ≥ 60 years |
135 129 153 125 131 |
286 336 304 223 357 |
112 112 136 99 100 |
|
Drug costs ≤ 19 years 20–39 years 40–59 years ≥ 60 years |
134 4 346 54 63 |
6 -35 250 -162 222 |
155 8 351 103 44 |
|
Costs of sick pay ≤ 19 years 20–39 years 40–59 years ≥ 60 years |
112 1 16 298 -65 |
707 40 350 993 123 |
21 1 -57 124 -88 |
|
Other healthcare costs ≤ 19 years 20–39 years 40–59 years ≥ 60 years |
7 -321 17 111 -1 |
254 6 252 120 770 |
-32 341 -15 106 -108 |
Abbreviations: C19 COVID-19, PCS Post-COVID-19 Syndrome